Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, OX3 7LE
MA MD FRCS (Paed.Surg) FAAP
Director of Oxford Islet Isolation and Islet Transplant Programmes and Professor of Paediatric Surgery
- Academic Training Programme Director for OUCAGS School of Surgery
- Fellow & Clinical Tutor, St Edmund Hall, University of Oxford
I am Professor of Paediatric Surgery at the University of Oxford, and Director of the Oxford Islet Transplant Programme. I am a Fellow and Clinical Tutor at St Edmund Hall. I qualified in Medicine from the University of Leicester and trained in Paediatric Surgery in Oxford, Melbourne and Great Ormond Street. My particular clinical interests are paediatric and endocrine surgery, and cell transplantation. My research interests include optimising human islet isolation, and understanding normal pancreatic development and islet neogenesis. I was awarded a Hunterian Professorship from the Royal College of Surgeons of England for this research in 1998. I am currently Immediate Past President of the International Pancreas and Islet Association (IPITA) having served as President from 2011-2013. I was awarded an Honorary Fellowship of The American Academy of Paediatrics in February 2010. I currently sit on a number of Research Boards and Editorial Boards. I chair the Nuffield Department of Surgical Sciences Clinical Academic Sub Group.
APSU - The Academic Paediatric Surgery Unit (APSU) undertakes research ranging from basic laboratory science to evidence-based clinical studies. The principal area of research relates to the endocrine pancreas, and in particular the field of pancreatic islet transplantation for juvenile-onset diabetes. The research group comprises clinicians, basic scientists, research fellows, clinical nurse specialists and technicians. Members of the group are currently working towards PhD, MD and MSc degrees.
OXCIT – The Oxford Consortium for Islet Transplantation (OXCIT) is a multi-disciplinary team that aims to achieve insulin independence in patients with diabetes by transplanting pancreatic islets of Langerhans. By simultaneously engaging in detailed basic and clinical research, it is anticipated that the OXCIT team will enable islet transplantation to be applied to children with diabetes in the future.
Basement membrane proteins improve human islet survival in hypoxia: Implications for islet inflammation.
Brandhorst D. et al, (2022), Acta Biomater, 137, 92 - 102
Bradshaw CJ. and Johnson P., (2022), Surgery (United Kingdom)
105.2: Pancreas and Islet Transplantation in the UK During the COVID-19 Era
Counter C. et al, (2021), Transplantation
Developing a morphomics framework to optimize implant site-specific design parameters for islet macroencapsulation devices.
McDermott B. et al, (2021), J R Soc Interface, 18
Pancreas and Islet Transplantation in the UK During the COVID-19 Era
Counter C. et al, (2021), TRANSPLANTATION, 105, S2 - S2